EPISODE · May 16, 2025 · 21 MIN
The FDA is Taking a Big Risk on AI
from CareTalk: Healthcare. Unfiltered. · host CareTalk: Healthcare. Unfiltered.
Send us Fan MailThe FDA is charging ahead with generative AI, claiming it can cut scientific review times from days to minutes. But is this innovation or recklessness? In this episode of CareTalk, David Williams and John Driscoll debate whether the FDA’s rapid deployment of AI is a smart move or a potentially dangerous shortcut.Stream our episode with FDA leader, Dr. Marty Makary, here. 🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSubscribe to the CareTalk NewsletterSupport the show⚙️CareTalk: Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.
Embed this episode
What this episode covers
Send us Fan Mail The FDA is charging ahead with generative AI, claiming it can cut scientific review times from days to minutes. But is this innovation or recklessness? In this episode of CareTalk, David Williams and John Driscoll debate whether the FDA’s rapid deployment of AI is a smart move or a potentially dangerous shortcut. Stream our episode with FDA leader, Dr. Marty Makary, here. 🎙️⚕️ABOUT CARETALK CareTalk is a weekly podcast that provides an incisive, no B.S. view of th...
NOW PLAYING
The FDA is Taking a Big Risk on AI
No transcript for this episode yet
Similar Episodes
No similar episodes found.